117 related articles for article (PubMed ID: 11406471)
1. HMG-CoA reductase inhibitor stabilizes rabbit atheroma by increasing basal NO and decreasing superoxide.
Thakur NK; Hayashi T; Sumi D; Kano H; Tsunekawa T; Iguchi A
Am J Physiol Heart Circ Physiol; 2001 Jul; 281(1):H75-83. PubMed ID: 11406471
[TBL] [Abstract][Full Text] [Related]
2. A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action.
Sumi D; Hayashi T; Thakur NK; Jayachandran M; Asai Y; Kano H; Matsui H; Iguchi A
Atherosclerosis; 2001 Apr; 155(2):347-57. PubMed ID: 11254905
[TBL] [Abstract][Full Text] [Related]
3. A HMG-CoA reductase inhibitor improved regression of atherosclerosis in the rabbit aorta without affecting serum lipid levels: possible relevance of up-regulation of endothelial NO synthase mRNA.
Kano H; Hayashi T; Sumi D; Esaki T; Asai Y; Thakur NK; Jayachandran M; Iguchi A
Biochem Biophys Res Commun; 1999 Jun; 259(2):414-9. PubMed ID: 10362523
[TBL] [Abstract][Full Text] [Related]
4. Preservation of endothelial function by the HMG-CoA reductase inhibitor fluvastatin through its lipid-lowering independent antioxidant properties in atherosclerotic rabbits.
Mitani H; Egashira K; Ohashi N; Yoshikawa M; Niwa S; Nonomura K; Nakashima A; Kimura M
Pharmacology; 2003 Jul; 68(3):121-30. PubMed ID: 12784083
[TBL] [Abstract][Full Text] [Related]
5. Estriol retards and stabilizes atherosclerosis through an NO-mediated system.
Kano H; Hayashi T; Sumi D; Matusi-Hirai H; Tsunekawa T; Endo H; Iguchi A
Life Sci; 2002 May; 71(1):31-42. PubMed ID: 12020746
[TBL] [Abstract][Full Text] [Related]
6. Gene transfer of endothelial NO synthase, but not eNOS plus inducible NOS, regressed atherosclerosis in rabbits.
Hayashi T; Sumi D; Juliet PA; Matsui-Hirai H; Asai-Tanaka Y; Kano H; Fukatsu A; Tsunekawa T; Miyazaki A; Iguchi A; Ignarro LJ
Cardiovasc Res; 2004 Feb; 61(2):339-51. PubMed ID: 14736551
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin reduces endothelial NOS: caveolin-1 ratio but not the phosphorylation status of eNOS in vivo.
Arora R; Hare DL; Zulli A
J Atheroscler Thromb; 2012; 19(8):705-11. PubMed ID: 22850448
[TBL] [Abstract][Full Text] [Related]
8. [Effect of HMG-CoA reductase inhibition on endothelial dysfunction-inducing protein in hypercholesterolemic rabbits].
Jiménez AM; Millás I; Farré J; García-Méndez A; Jiménez P; Arriero MM; García-Colis E; de Andrés R; Gómez J; Casado S; López-Farré A
Rev Esp Cardiol; 2002 Nov; 55(11):1151-8. PubMed ID: 12423572
[TBL] [Abstract][Full Text] [Related]
9. The changes in the endothelial expression of cell adhesion molecules and iNOS in the vessel wall after the short-term administration of simvastatin in rabbit model of atherosclerosis.
Nachtigal P; Kopecky M; Solichova D; Zdansky P; Semecky V
J Pharm Pharmacol; 2005 Feb; 57(2):197-203. PubMed ID: 15720783
[TBL] [Abstract][Full Text] [Related]
10. Effects of HMG-CoA reductase inhibition by simvastatin on vascular dysfunction induced by lipopolysaccharide in rats.
Alvarez de Sotomayor M; Vega S; Mingorance C; Marhuenda E; Herrera MD
Pharmacology; 2008; 82(2):89-96. PubMed ID: 18509252
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide synthase II (NOS II) gene expression correlates with atherosclerotic intimal thickening. Preventive effects of HMG-CoA reductase inhibitors.
Alfon J; Guasch JF; Berrozpe M; Badimon L
Atherosclerosis; 1999 Aug; 145(2):325-31. PubMed ID: 10488960
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.
Laufs U; La Fata V; Plutzky J; Liao JK
Circulation; 1998 Mar; 97(12):1129-35. PubMed ID: 9537338
[TBL] [Abstract][Full Text] [Related]
13. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation.
Wagner AH; Köhler T; Rückschloss U; Just I; Hecker M
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):61-9. PubMed ID: 10634801
[TBL] [Abstract][Full Text] [Related]
14. Influence of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors on endothelial nitric oxide synthase and the formation of oxidants in the vasculature.
Parker RA; Huang Q; Tesfamariam B
Atherosclerosis; 2003 Jul; 169(1):19-29. PubMed ID: 12860247
[TBL] [Abstract][Full Text] [Related]
15. HMG-CoA reductase inhibitor, fluvastatin, has cholesterol-lowering independent "direct" effects on atherosclerotic vessels in high cholesterol diet-fed rabbits.
Mitani H; Egashira K; Kimura M
Pharmacol Res; 2003 Nov; 48(5):417-27. PubMed ID: 12967585
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin restores endothelial NO-mediated vasorelaxation in large arteries after myocardial infarction.
Bates K; Ruggeroli CE; Goldman S; Gaballa MA
Am J Physiol Heart Circ Physiol; 2002 Aug; 283(2):H768-75. PubMed ID: 12124226
[TBL] [Abstract][Full Text] [Related]
17. HMG-CoA reductase inhibitors inhibit endothelial exocytosis and decrease myocardial infarct size.
Yamakuchi M; Greer JJ; Cameron SJ; Matsushita K; Morrell CN; Talbot-Fox K; Baldwin WM; Lefer DJ; Lowenstein CJ
Circ Res; 2005 Jun; 96(11):1185-92. PubMed ID: 15905463
[TBL] [Abstract][Full Text] [Related]
18. Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E.
Wang YX; Martin-McNulty B; Huw LY; da Cunha V; Post J; Hinchman J; Vergona R; Sullivan ME; Dole W; Kauser K
Atherosclerosis; 2002 May; 162(1):23-31. PubMed ID: 11947894
[TBL] [Abstract][Full Text] [Related]
19. Characterization of endothelial factors involved in the vasodilatory effect of simvastatin in aorta and small mesenteric artery of the rat.
Alvarez De Sotomayor M; Herrera MD; Marhuenda E; Andriantsitohaina R
Br J Pharmacol; 2000 Nov; 131(6):1179-87. PubMed ID: 11082126
[TBL] [Abstract][Full Text] [Related]
20. [Effects of Tongxinluo and Simvastatin on the stabilization of vulnerable atherosclerotic plaques of aorta in aortic atherosclerosis and molecular mechanism thereof: a comparative study with rabbits].
Li Z; Yang YJ; Qin XW; Ruan YM; Chen X; Meng L; Zhang HD
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3146-50. PubMed ID: 17313769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
